GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curative Biotechnology Inc (OTCPK:CUBT) » Definitions » Total Assets

Curative Biotechnology (Curative Biotechnology) Total Assets : $2.13 Mil (As of Mar. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Curative Biotechnology Total Assets?

Curative Biotechnology's Total Assets for the quarter that ended in Mar. 2023 was $2.13 Mil.

Total Assets is connected with ROA %. Curative Biotechnology's annualized ROA % for the quarter that ended in Mar. 2023 was -183.08%. Total Assets is also linked to Revenue through Asset Turnover. Curative Biotechnology's Asset Turnover for the quarter that ended in Mar. 2023 was 0.00.


Curative Biotechnology Total Assets Historical Data

The historical data trend for Curative Biotechnology's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biotechnology Total Assets Chart

Curative Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Assets
Get a 7-Day Free Trial 0.05 0.04 2.27 2.41 2.09

Curative Biotechnology Quarterly Data
Dec16 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.20 2.03 2.01 2.09 2.13

Curative Biotechnology Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Curative Biotechnology's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Assets=Total Equity (A: Dec. 2022 )+Total Liabilities (A: Dec. 2022 )
=-20.53+22.619
=2.09

Curative Biotechnology's Total Assets for the quarter that ended in Mar. 2023 is calculated as

Total Assets=Total Equity (Q: Mar. 2023 )+Total Liabilities (Q: Mar. 2023 )
=-17.912+20.044
=2.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curative Biotechnology  (OTCPK:CUBT) Total Assets Explanation

Total Assets is connected with ROA %.

Curative Biotechnology's annualized ROA % for the quarter that ended in Mar. 2023 is

ROA %=Net Income (Q: Mar. 2023 )/( (Total Assets (Q: Dec. 2022 )+Total Assets (Q: Mar. 2023 ))/ count )
=-3.864/( (2.089+2.132)/ 2 )
=-3.864/2.1105
=-183.08 %

Note: The Net Income data used here is four times the quarterly (Mar. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Curative Biotechnology's Asset Turnover for the quarter that ended in Mar. 2023 is

Asset Turnover
=Revenue (Q: Mar. 2023 )/( (Total Assets (Q: Dec. 2022 )+Total Assets (Q: Mar. 2023 ))/ count )
=0/( (2.089+2.132)/ 2 )
=0/2.1105
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Curative Biotechnology Total Assets Related Terms

Thank you for viewing the detailed overview of Curative Biotechnology's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Curative Biotechnology (Curative Biotechnology) Business Description

Traded in Other Exchanges
N/A
Address
1825 NW Corporate Boulevard, Suite 110, Boca Raton, FL, USA, 33431
Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The company currently has ongoing programs in three therapeutic areas: Infectious Disease, Neuro-Oncology, and Degenerative Eye Disease.